Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Current Pain and Headache Reports
Published in: Current Pain and Headache Reports 4/2012

01-08-2012 | Invited Commentary

Complementary Medicine in Cancer Care: Adding a Therapy Dog to the Team

Author: Dawn A. Marcus

Published in: Current Pain and Headache Reports | Issue 4/2012

Login to get access

Abstract

Animal-assisted therapy, including visits from certified therapy dogs, offer a valuable and often underutilized resource for addressing unmet needs in cancer patients. Prospective research studies have documented symptomatic benefits for reducing pain, psychological distress, and fatigue in a variety of patient populations, including cancer patients. Utilizing consistent policies minimizes patient risk and infection control concerns associated with animal visits.
Literature
1.
Soothill K, Morris SM, Thomas C, et al. The universal, situational, and personal needs of cancer patients and their main carers. Eur J Oncol Nurs. 2003;7:5–16.PubMedCrossRef
2.
Horneber M, Bueschel G, Dennert G, Less D, Ritter E, Zwahlen M. How many cancer patients use complementary and alternative medicine: a systematic review and metaanalysis. Integr Cancer Ther. Epub 2011 Oct 21.
3.
Söllner W, Maislinger S, DeVries A, et al. Use of complementary and alternative medicine by cancer patients is not associated with perceived distress or poor compliance with standard treatment but with active coping behavior: a survey. Cancer. 2000;89:873–80.PubMedCrossRef
4.
Heese O, Schmidt M, Nickel S, et al. Complementary therapy use in patients with glioma: an observational study. Neurology. 2010;75:2229–35.PubMedCrossRef
5.
Jia L. Cancer complementary and alternative medicine research at the US National Cancer Institute. Chin J Integr Med. Epub 2012 Jan 12.
6.
Marcus DA. Therapy dogs in cancer care: a valuable complementary treatment. New York: Springer; 2012.
7.
Coakley AB, Mahoney EK. Creating a therapeutic and healing environment with a pet therapy program. Complement Ther Clin Pract. 2009;15:141–6.PubMedCrossRef
8.
Marcus DA, Bernstein CD, Constantin JM, Kunkel FA, Breuer P, Hanlon RB. Animal-assisted therapy at an outpatient pain management clinic. Pain Med. 2012;13:45–57.PubMedCrossRef
9.
Orlandi M, Trangeled K, Mambrini A, et al. Pet therapy effects on oncological day hospital patients undergoing chemotherapy treatment. Anticancer Res. 2007;27:4301–4.PubMed
10.
Lander DA, Graham-Pole JR. Love medicine for the dying and their caregivers: the body of evidence. J Health Psychol. 2008;13:201–12.PubMedCrossRef
11.
Bercovitz A, Sengupta M, Jones A, Harris-Kojetin LD. Complementary and alternative therapies in hospice: the National Home and Hospice Care Survey: United States, 2007. Natl Health Stat Rep. 2011;33:1–20.
12.
Muschel IJ. Pet therapy with terminal cancer patients. Soc Casework. 1984;65:451–8.PubMed
13.
LeFebvre SL, Golab GC, Christensen E, et al. Guidelines for animal-assisted interventions in health care facilities. Am J Infect Control. 2008;36:78–85.PubMedCrossRef
14.
Caprilli S, Messeri A. Animal-assisted activity at A. Meyer Children’s Hospital: a pilot study. Evid Based Complement Alternat Med. 2006;3:379–83.PubMedCrossRef
15.
Carlson LE, Angen M, Cullum J, et al. High levels of untreated distress and fatigue in cancer patients. Br J Cancer. 2004;90:2297–304.PubMed
16.
Lutgendorf SK, Sood AK, Antoni MH. Host factors and cancer progression: biobehavioral signaling pathways and interventions. J Clin Oncol. 2010;28:4094–9.PubMedCrossRef
17.
Armaiz-Pena GN, Lutgendorf SK, Cole SW, Sood AK. Neuroendocrine modulation of cancer progression. Brain Behav Immun. 2009;23:10–5.PubMedCrossRef
18.
Lutgendorf SK, DeGeest K, Dahmoush L, et al. Social isolation is associated with elevated tumor norepinephrine in ovarian carcinoma patients. Brain Behav Immun. 2011;25:250–5.PubMedCrossRef
19.
Block KI. Cost savings with clinical solutions: the impact of reforming health and health care economics with integrative therapies. Integr Cancer Ther. 2010;9:129–35.PubMedCrossRef
20.
Cangelosi PR, Sorrell JM. Walking for therapy with man’s best friend. J Psychosoc Nurs Ment Health Serv. 2010;48:19–22.PubMed
Metadata
Title
Complementary Medicine in Cancer Care: Adding a Therapy Dog to the Team
Author
Dawn A. Marcus
Publication date
01-08-2012
Publisher
Current Science Inc.
Published in
Current Pain and Headache Reports / Issue 4/2012
Print ISSN: 1531-3433
Electronic ISSN: 1534-3081
DOI
https://doi.org/10.1007/s11916-012-0264-0

Other articles of this Issue 4/2012

Current Pain and Headache Reports 4/2012 Go to the issue

Cancer Pain (DA Marcus, Section editor)

Spinal Cord Stimulation in the Treatment of Cancer-Related Pain: “Back to the Origins”

Cancer Pain (DA Marcus, Section editor)

Expectations of Pain and Accompanying Symptoms during Cancer Treatment

Invited Commentary

Expert Commentary–Unusual Headache Syndromes

Uncommon Headache Syndromes (ME Bigal, Section editor)

Headache and Temporal Arteritis: When to Suspect and How to Manage

Cancer Pain (DA Marcus, Section editor)

The Role of Corticosteroids in the Treatment of Pain in Cancer Patients

Uncommon Headache Syndromes (ME Bigal, Section editor)

How to Investigate and Treat: Migraine in Patients with Temporomandibular Disorders